Search Results - Kurtovic, Sabira

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    The effects of mutational profiles on phenotypic presentation of myeloproliferative neoplasm subtypes in Bosnia: 18 year follow-up

    The effects of mutational profiles on phenotypic presentation of myeloproliferative neoplasm subtypes in Bosnia: 18 year follow-up by Kurtovic-Kozaric, Amina, Islamagic, Erna, Komic, Hana, Bilalovic, Nurija, Eminovic, Izet, Burekovic, Adnan, Uzunovic, Amna, Kurtovic, Sabira

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma

    A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma by Collins, Graham P., Eyre, Toby A., Schmitz‐Rohmer, Debora, Townsend, William, Popat, Rakesh, Giulino‐Roth, Lisa, Fields, Paul A., Krasniqi, Fatime, Soussain, Carole, Stathis, Anastasios, Andjelkovic, Nebojsa, Cunningham, David, Mandic, Danijela, Radulovic, Sinisa, Tijanic, Ivan, Horowitz, Netanel A., Kurtovic, Sabira, Schorb, Elisabeth, Schmidt, Christian, Dimitrijević, Saša, Dreyling, Martin

    Published in HemaSphere
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Real-World Management of Chronic Myeloid Leukemia in Bosnia and Herzegovina: Treatment Patterns, Molecular Monitoring, and Outcomes

    Real-World Management of Chronic Myeloid Leukemia in Bosnia and Herzegovina: Treatment Patterns, Molecular Monitoring, and Outcomes by Kurtovic-Kozaric, Amina, Islamagic, Erna, Hasic, Azra, Mehinovic-Cavcic, Lejla, Komic, Hana, Kurtovic, Sabira

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The Comparison of Efficacy Between Generic and Branded Imatinib in Achievement of Overall Survival and Cytogenetic Responses in CML Patients in Bosnia and Herzegovina

    The Comparison of Efficacy Between Generic and Branded Imatinib in Achievement of Overall Survival and Cytogenetic Responses in CML Patients in Bosnia and Herzegovina by Kozaric, Amina Kurtovic, Islamagic, Erna, Radich, Jerald P., Suljovic Hadzimesic, Emina, Hasic, Azra, Kurtovic, Sabira

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    The Efficacy of Generic Imatinib as First- and Second-line Therapy: 3-Year Follow-up of Patients With Chronic Myeloid Leukemia

    The Efficacy of Generic Imatinib as First- and Second-line Therapy: 3-Year Follow-up of Patients With Chronic Myeloid Leukemia by Islamagic, Erna, Hasic, Azra, Kurtovic, Sabira, Suljovic Hadzimesic, Emina, Mehinovic, Lejla, Kozaric, Mirza, Kurtovic-Kozaric, Amina

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    The reality of cancer treatment in a developing country: the effects of delayed TKI treatment on survival, cytogenetic and molecular responses in chronic myeloid leukaemia patients

    The reality of cancer treatment in a developing country: the effects of delayed TKI treatment on survival, cytogenetic and molecular responses in chronic myeloid leukaemia patients by Kurtovic‐Kozaric, Amina, Hasic, Azra, Radich, Jerald P., Bijedic, Vildan, Nefic, Hilada, Eminovic, Izet, Kurtovic, Sabira, Colakovic, Ferida, Kozaric, Mirza, Vranic, Semir, Bovan, Nada S.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Long-term outcome of GIST patients treated with delayed imatinib therapy

    Long-term outcome of GIST patients treated with delayed imatinib therapy by Kurtovic-Kozaric, Amina, Kugic, Amina, Hasic, Azra, Beslija, Semir, Ceric, Timur, Pasic, Anes, Vranic, Semir, Kopric, Dijana, Iljazovic, Ermina, Todorovic Barbuscia, Jelena, Kozaric, Mirza, Ibisevic, Nermina, Keskic, Leila, Kurtovic, Sabira

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Lack of Access to Targeted Cancer Treatment Modalities in the Developing World in the Era of Precision Medicine: Real-Life Lessons From Bosnia

    Lack of Access to Targeted Cancer Treatment Modalities in the Developing World in the Era of Precision Medicine: Real-Life Lessons From Bosnia by Kurtovic-Kozaric, Amina, Vranic, Semir, Kurtovic, Sabira, Hasic, Azra, Kozaric, Mirza, Granov, Nermir, Ceric, Timur

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    The efficacy of generic imatinib as first- and second-line therapy: three year follow-up of chronic myeloid leukemia patients

    The efficacy of generic imatinib as first- and second-line therapy: three year follow-up of chronic myeloid leukemia patients by Islamagic, Erna, Ms, Hasic, Azra, MD, Kurtovic, Sabira, MD, Hadzimesic, Emina Suljovic, MD, Mehinovic, Lejla, Ms, Kozaric, Mirza, MD, Kurtovic-Kozaric, Amina, PhD

    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    The MAXIMA Study: Safety of Rituximab (MabThera®) Maintenance Therapy in Patients with Follicular Non-Hodgkin's Lymphoma Who Have Responded to Induction Therapy

    The MAXIMA Study: Safety of Rituximab (MabThera®) Maintenance Therapy in Patients with Follicular Non-Hodgkin's Lymphoma Who Have Responded to Induction Therapy by Wenger, Michael K., Foa, Robin, Arcaini, Luca, Vranovský, Andrej, Ivanova, Valentina, Guy, Van Hazel, Kurtovic, Sabira, Durán, Soledad, McKechnie, Stephen, Thurley, Daniel

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: